Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Tolazoline hydrochloride

Related Products

Hot Products

Basic Information Post buying leads Suppliers
Name

Tolazoline hydrochloride

EINECS 200-447-3
CAS No. 59-97-2 Density 1.09g/cm3
PSA 24.39000 LogP 1.79720
Solubility N/A Melting Point 172-176 °C
Formula C10H12N2.HCl Boiling Point 338.2 °C at 760 mmHg
Molecular Weight 196.68 Flash Point 158.3 °C
Transport Information N/A Appearance Pale yellow crystalline solid
Safety 22 Risk Codes 22
Molecular Structure Molecular Structure of 59-97-2 (Tolazoline hydrochloride) Hazard Symbols HarmfulXn
Synonyms

1H-Imidazole,4,5-dihydro-2-(phenylmethyl)-, monohydrochloride (9CI);2-Imidazoline, 2-benzyl-,monohydrochloride (8CI);2-Benzyl-2-imidazoline hydrochloride;2-Benzyl-4,5-dihydroimidazole hydrochloride;2-Benzylimidazoline hydrochloride;Arterodyl;Benzazoline hydrochloride;Imidaline hydrochloride;Lambral;Priscoline hydrochloride;Tolavad;Tolazoline chloride;Tolazolinehydrochloride;Tolpal;Totazoline;Vaso-Dilatan;

 

Tolazoline hydrochloride Consensus Reports

Reported in EPA TSCA Inventory.

Tolazoline hydrochloride Specification

The Benzazoline hydrochloride is an organic compound with the formula C10H12N2.HCl. The IUPAC name of this chemical is 2-benzyl-4,5-dihydro-1H-imidazole hydrochloride. With the CAS registry number 59-97-2, it is also named as (4-chlorophenyl)piperazine. The product's categories are Intermediates & Fine Chemicals; Pharmaceuticals. Besides, it is a pale yellow crystalline solid, which should be stored in a closed place. It is used for biological research and medicine.

Physical properties about Benzazoline hydrochloride are: (1)ACD/LogP: 1.84; (2)ACD/LogD (pH 5.5): -0.91; (3)ACD/LogD (pH 7.4): 0.71; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1.09; (6)ACD/KOC (pH 5.5): 1; (7)ACD/KOC (pH 7.4): 17.58; (8)#H bond acceptors: 2; (9)#H bond donors: 1; (10)#Freely Rotating Bonds: 1; (11)Polar Surface Area: 6.48 Å2; (12)Index of Refraction: 1.557; (13)Molar Refractivity: 54.7 cm3; (14)Molar Volume: 169.6 cm3; (15)Polarizability: 21.68×10-24cm3; (16)Surface Tension: 39.7 dyne/cm; (17)Density: 1.159 g/cm3; (18)Flash Point: 157.2 °C; (19)Enthalpy of Vaporization: 57.94 kJ/mol; (20)Boiling Point: 336.3 °C at 760 mmHg; (21)Vapour Pressure: 0.000113 mmHg at 25°C.

Uses of Benzazoline hydrochloride: it can be used to produce (1H-imidazol-2-yl)-phenyl-methanone by heating. It will need reagent sodium acetate, KMnO4 and solvent dioxane with reaction time of 24 hours. The yield is about 42%.

When you are using this chemical, please be cautious about it as the following:
This chemical is harmful if swallowed. When you are using it, do not breathe dust.

You can still convert the following datas into molecular structure:
(1)SMILES: Clc1ccc(cc1)N2CCNCC2
(2)InChI: InChI=1/C10H13ClN2/c11-9-1-3-10(4-2-9)13-7-5-12-6-8-13/h1-4,12H,5-8H2
(3)InChIKey: UNEIHNMKASENIG-UHFFFAOYAT
(4)Std. InChI: InChI=1S/C10H13ClN2/c11-9-1-3-10(4-2-9)13-7-5-12-6-8-13/h1-4,12H,5-8H2
(5)Std. InChIKey: UNEIHNMKASENIG-UHFFFAOYSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
human TDLo intravenous 150ug/kg (0.15mg/kg) CARDIAC: CHANGE IN RATE

VASCULAR: OTHER CHANGES

SKIN AND APPENDAGES (SKIN): SWEATING: OTHER
Folia Medica Vol. 27, Pg. 729, 1941.
infant TDLo intravenous 48mg/kg/47H-C (48mg/kg) GASTROINTESTINAL: ULCERATION OR BLEEDING FROM DUODENUM

GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE
Australian Paediatric Journal. Vol. 22, Pg. 221, 1986.
mouse LD50 intraperitoneal 130mg/kg (130mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 1992, 1971.
mouse LD50 intravenous 56700ug/kg (56.7mg/kg) PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Journal of Pharmacobio-Dynamics. Vol. 9, Pg. 395, 1986.
mouse LD50 oral 400mg/kg (400mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 1992, 1971.
rat LD50 intraperitoneal 100mg/kg (100mg/kg)   Drugs in Japan Vol. 6, Pg. 511, 1982.
rat LD50 intravenous 85mg/kg (85mg/kg)   Drugs in Japan Vol. 6, Pg. 511, 1982.
rat LD50 oral 1200mg/kg (1200mg/kg)   Drugs in Japan Vol. 6, Pg. 511, 1982.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 59-97-2